Colossal Biosciences Hits $10B Valuation, Set to Resurrect Extinct Animals
Colossal Biosciences Reaches $10 Billion Valuation
Colossal Biosciences has achieved a remarkable milestone by reaching a $10 billion valuation. This accomplishment places the Dallas-based startup in an elite group of companies, marking it as the first Texas startup to attain such a high valuation. The company's rapid growth since its launch in September 2021 highlights its significant impact in the field of genetic engineering.
Funding Milestone and Key Investors
The company secured a substantial $200 million in Series C financing from TWG Global, led by Mark Walter of Guggenheim Capital. This funding brings Colossal's total investments to $435 million, showcasing strong investor confidence. Notable backers include adventurer Victor Vescovo and renowned director Peter Jackson, underscoring the diverse support for Colossal's innovative vision.
Mission and Goals: Resurrecting Extinct Species
Colossal Biosciences aims to use gene editing technology to bring extinct animals back to life. With a team of 170 scientists across three labs, the company is dedicated to making extinction a thing of the past. CEO Ben Lamm emphasized that the new funding will help expand their team and develop new technologies to support their ambitious mission.
Current De-Extinction Projects
The startup is actively working on bringing back the woolly mammoth, the dodo bird, and the thylacine, also known as the Tasmanian tiger. Colossal has successfully developed genomes for these species and created an artificial uterus to cultivate their embryos. In the case of the dodo bird, the company has made significant progress by editing the DNA of Nicobar pigeons to create chimeric chicks, which could serve as surrogates for the extinct species.
Technological Advances and Conservation Efforts
Colossal is not only focused on de-extinction but also on broader conservation and biology projects. These include ancient DNA research, artificial intelligence tools for elephant and bird conservation, and advanced reproductive techniques for endangered Sumatran rhinos. Chief Science Officer Beth Shapiro highlighted that these technological advances are crucial for protecting and restoring endangered species and ecosystems.
Conclusion: Pioneering the Battle Against Extinction
With the pressing global extinction crisis, Colossal Biosciences is at the forefront of innovative solutions to preserve biodiversity. The company's efforts address significant environmental challenges such as land desertification, water scarcity, and food insecurity. By leveraging cutting-edge genetic engineering and synthetic biology, Colossal is transforming what was once considered science fiction into tangible, impactful conservation efforts.
Read the full article here:
dallasnews.com